SCHEMBL5334463

SCHEMBL5334463

CCCc1ccc(C(=O)Nc2ccc3sc(C)nc3c2Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.45
POLB P06746 3/20 0.45
ALDH1A1 P00352 2/20 0.45
CTDSP1 Q9GZU7 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
P2RY14 Q15391 1/20 0.43
PLK1 P53350 6/20 0.43
TRPV1 Q8NER1 2/20 0.42
HSD11B1 P28845 1/20 0.42
HPGD P15428 2/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5340796 0.82 RAB9A (0.53) ALDH1A1KDM4ENPC1RAB9AHPGD
SCHEMBL14484090 0.82 RAB9A (0.53) KDM4ENPC1RAB9AHSD11B1HPGD
SCHEMBL5337736 0.80 HSD11B1 (0.51) ALDH1A1KDM4ENPC1RAB9ATRPV1
SCHEMBL5344604 0.76 MAPT (0.53) GAAALDH1A1KDM4ENPC1RAB9A
SCHEMBL5335168 0.75 TRPV1 (0.69) POLBNPC1RAB9ATRPV1MAPT
SCHEMBL5338394 0.74 MAPT (0.55) POLBKDM4ENPC1RAB9AHPGD
SCHEMBL5315753 0.73 NPC1 (0.70) GAAPOLBALDH1A1KDM4ENPC1
SCHEMBL5340071 0.73 HSD11B1 (0.59) ALDH1A1NPC1RAB9AHSD11B1MAPT
SCHEMBL14484121 0.72 KMT2A (0.57) ALDH1A1NPC1RAB9AMAPTMEN1
SCHEMBL5333962 0.72 LMNA (0.53) ALDH1A1KDM4ERAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US claimed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 GAA 3695/4885POLB 1599/4885ALDH1A1 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.